Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing. . . . → Read More: Crispr Diagnostics Company Launches with $35M Funding
|
|||||
|
|
A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics. . . . → Read More: Spin-Off Producing Commercial-Grade Graphene 
A start-up company spun off from Purdue University is developing a system that translates visual images to touch-sensing signals for people with limited visual abilities. . . . → Read More: Start-Up Creating Touch Sensing for Visual Images  Comments are closed  Intellectual property, New products  biomedical, computer science, engineering, entrepreneurs, licensing, life sciences, mathematics, NSF, patent, physical sciences, software, university 
A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round. . . . → Read More: Start-Up Raises $10.5M for Precision Immunotherapies One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, preclinical, venture capital 
Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as well as hundreds of licenses and patents. . . . → Read More: MIT Spins-Off 32 Start-Ups in 2018 Comments are closed Intellectual property, Joint ventures/collaborations economics, energy, entrepreneurs, investment, licensing, life sciences, patent, physical sciences, university 
University of California in Berkeley will soon receive a new patent for its development of the genome editing process known as Crispr, the latest round in a years-long dispute. . . . → Read More: UC-Berkeley to Get New Crispr Patent One comment - (Comments are closed) Intellectual property biomedical, biotechnology, entrepreneurs, Europe, genomics, licensing, life sciences, patent, USPTO 
A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing. . . . → Read More: Company to Stop Cancer Spread, Relapse Raises $60.8M 2 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, entrepreneurs, equity, investment, licensing, life sciences, medical device, pharmaceuticals, university, venture capital 
Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain. . . . → Read More: Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, clinical trials, equity, Europe, investment, licensing, life sciences, pharmaceuticals 
Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules 2 comments - (Comments are closed) Intellectual property, New products biomedical, engineering, entrepreneurs, HIV, licensing, life sciences, materials science, patent, pharmaceuticals, physical sciences, university, USPTO 
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas. . . . → Read More: Janssen Licensing Cancer Antibodies in $1.8B Deal Comments are closed Finance, Intellectual property biomedical, biotechnology, cancer, clinical trials, equity, Europe, investment, licensing, life sciences, pharmaceuticals, stem cells |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||